Health ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients by Alexandra Hartman Editor-in-Chief June 4, 2023 written by Alexandra Hartman Editor-in-Chief June 4, 2023 46 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children next post Amazon is negotiating with US carriers to provide low-cost mobile phone service You may also like 10,000 Years of Art: Ancient Rock Shelter Discovered... February 15, 2026 Neuer Subbed Off: Bayern Munich Goalkeeper’s Early Exit... February 15, 2026 IVF Genetic Tests: Do They Really Predict a... February 15, 2026 Wichita DJ ‘The Hitman’ Battles Stage 4 Cancer... February 15, 2026 Sleeping at Work: 34% of Brazilians Admit to... February 15, 2026 Colorectal Cancer: Symptoms, Prevention & What to Know... February 15, 2026 Tết & Your Gut: Eating Well to Avoid... February 15, 2026 Kelly Osbourne’s Transformation: Ozempic Face or Diet &... February 15, 2026 Designer Babies: Parents Choose Embryo for Traits Like... February 15, 2026 Feline Panleukopenia Outbreak: Cats in Lelystad Affected –... February 15, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
